🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
565,72 USD
Máx. histórico
608,49
1 días
Split 2:1 del 23/09/2009
Caída desde máximo
-7,03%
Rango 52 semanas
444,04 – 614,23
Variación hoy
-7,03%
Cierre anterior
608,49
Rango de hoy
561,24 – 608,04
Volumen hoy
602.001
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,96%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,36 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 7 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/09/2013 | 78,04 | 78,36 | 77,04 | 77,40 | -0,59% | 1,69% | 297.400 |
| 20/09/2013 | 79,00 | 79,47 | 77,77 | 77,86 | -1,03% | 2,15% | 432.300 |
| 19/09/2013 | 79,67 | 79,89 | 77,76 | 78,67 | -0,81% | 2,67% | 250.700 |
| 18/09/2013 | 79,54 | 79,54 | 78,03 | 79,31 | -0,34% | 1,90% | 230.200 |
| 17/09/2013 | 79,16 | 79,95 | 78,54 | 79,58 | +0,76% | 1,78% | 316.100 |
| 16/09/2013 | 78,71 | 79,19 | 77,68 | 78,98 | +1,79% | 1,92% | 243.900 |
| 13/09/2013 | 77,78 | 77,95 | 76,87 | 77,59 | +0,57% | 1,39% | 240.900 |
| 12/09/2013 | 77,36 | 77,92 | 76,18 | 77,15 | -0,26% | 2,25% | 318.500 |
| 11/09/2013 | 77,18 | 78,38 | 76,23 | 77,35 | +0,27% | 2,79% | 544.700 |
| 10/09/2013 | 76,61 | 77,17 | 75,23 | 77,14 | +1,85% | 2,53% | 662.200 |
| 09/09/2013 | 73,47 | 75,79 | 73,36 | 75,74 | +2,81% | 3,31% | 385.900 |
| 06/09/2013 | 74,29 | 74,29 | 72,28 | 73,67 | -0,67% | 2,71% | 316.400 |
| 05/09/2013 | 73,11 | 74,52 | 72,85 | 74,17 | +0,91% | 2,28% | 272.600 |
| 04/09/2013 | 72,38 | 73,65 | 72,03 | 73,50 | +2,04% | 2,24% | 436.500 |
| 03/09/2013 | 71,87 | 72,64 | 70,95 | 72,03 | +1,58% | 2,35% | 449.600 |
| 30/08/2013 | 73,27 | 73,27 | 70,68 | 70,91 | -3,02% | 3,53% | 260.100 |
| 29/08/2013 | 72,29 | 73,81 | 71,66 | 73,12 | +1,27% | 2,97% | 276.900 |
| 28/08/2013 | 71,33 | 72,38 | 70,34 | 72,20 | +1,28% | 2,86% | 421.300 |
| 27/08/2013 | 72,56 | 72,98 | 70,85 | 71,29 | -2,85% | 2,94% | 274.300 |
| 26/08/2013 | 72,04 | 73,85 | 71,66 | 73,38 | +2,40% | 3,04% | 229.500 |
| 23/08/2013 | 72,85 | 73,44 | 71,49 | 71,66 | -1,31% | 2,68% | 237.200 |
| 22/08/2013 | 72,05 | 73,03 | 71,79 | 72,61 | +0,96% | 1,72% | 296.400 |
| 21/08/2013 | 71,59 | 72,85 | 71,20 | 71,92 | -0,22% | 2,30% | 271.700 |
| 20/08/2013 | 70,62 | 72,58 | 70,62 | 72,08 | +1,89% | 2,78% | 303.200 |
| 19/08/2013 | 70,93 | 72,36 | 70,73 | 70,74 | -0,66% | 2,30% | 239.200 |
| 16/08/2013 | 71,06 | 72,38 | 70,58 | 71,21 | +0,10% | 2,53% | 350.300 |
| 15/08/2013 | 72,20 | 72,28 | 70,74 | 71,14 | -2,28% | 2,13% | 445.000 |
| 14/08/2013 | 73,90 | 74,08 | 72,78 | 72,80 | -1,30% | 1,76% | 722.000 |
| 13/08/2013 | 74,00 | 74,31 | 73,33 | 73,76 | +0,27% | 1,32% | 332.300 |
| 12/08/2013 | 73,66 | 73,75 | 72,91 | 73,56 | -0,26% | 1,14% | 190.100 |